Karmanos Cancer Institute, headquartered in Detroit, Michigan, is the largest cancer research and provider network in Michigan. It is one of 57 National Cancer Institute-designated comprehensive cancer centers in the United States. The institute cares for approximately 14,000 new patients annually and conducts over 700 cancer-specific scientific investigation programs and clinical trials.

Karmanos Cancer Institute specializes in:

• Medical oncology

• Radiation oncology

• Surgical oncology

• Hematology

• Bone marrow and stem cell transplantation

• Clinical trials and research

• Supportive and wellness services

• Karmanos Cancer Institute quality includes:

  • Accredited by The Joint Commission (JCAHO)

  • Affiliated with Wayne State University School of Medicine

  • One of the largest clinical trials programs in the nation

  • Multidisciplinary teams with nationally recognized experience

  • Comprehensive cancer care with access to over 250 new treatments

Vision:

• Karmanos Cancer Institute envisions a world free of cancer.

 Mission:

• Karmanos Cancer Institute is committed to leading in transformative cancer care, research, and education through courage, commitment, and compassion.

• Karmanos Cancer Institute has received:

  • 2025 Women’s Choice Award® for Cancer Care, Mammogram Imaging, Minimally Invasive Surgery, and Patient Experience

  • Recognition as one of America’s Best Hospitals for Cancer Care and Patient Experience by the Women’s Choice Award®

  • Designation as a comprehensive cancer center by the National Cancer Institute